Appili Names Balboni as CSO

Appili Therapeutics, a Halifax-based drug development company, has appointed its first ever Chief Scientific Officer.
Armand Balboni, the new CSO, will be responsible for the company’s clinical and scientific strategy as well as steering its programs through regulatory and pre-commercialization processes.
“Armand’s medical science, business, and military experience, including his particular